Alaris Lanka said that there has been a false and malicious campaign launched against their brand ‘Facia Premium’. The product is directly imported from Australia. Sadly, the campaign has received coverage in some print and social media.
Chairman and the Managing Director of Alaris Group of Companies Tharanga Weerawardana at a press conference said that a false letter bearing the letterhead of the National Medicine Regulatory Authority (NMRA) and a forged signature of CEO of the NMRA Dr Kamal Jayasinghe is being circulated. The fake letter states that the product Facia Premium has been banned in Sri Lanka.
“The product is used in Australia and over 10 countries around the world and the same product is sold in Sri Lanka by Alaris Lanka.”
The CEO of NMRA has denied the issuance of such a letter and instructed the Director of the Fraud Investigation Bureau to conduct an investigation on a priority basis.
Further, he stated that the two newspapers which published this news have immediately corrected the same after contacting the NMRA and Sri Lanka Customs. “Further Facebook has also taken necessary actions to mark these social media posts as ‘False Information.’”
“Although competitors have tried numerous times to tarnish the reputation of Alaris Lanka and Facia through the circulation of malicious false and misleading facts we are still strong. We as a responsible institution have been in the industry for more than 10 years. Alaris Lanka would like to notify their customers and the general public that we will continue to provide high quality and effective products. We continue to conduct our business ethically and professionally.”
The company has invested close to Rs. 1 billion to put up a modern pharma and cosmetic manufacturing plant in Horana. The company will invest more to locally produce pharmaceuticals for the local and export market.
0 comments: